Advisers to the Food and Drug Administration voted unanimously on Tuesday against the effectiveness of the key drug found in popular versions of Sudafed, Dayquil and other medications stocked on store shelves.
The FDA assembled its outside advisers to take another look at phenylephrine, which became the main drug in over-the-counter decongestants when medicines with an older ingredient — pseudoephedrine — were moved behind pharmacy counters. A 2006 law had forced the move because pseudoephedrine can be illegally processed into methamphetamine.
If the FDA follows through on the panel’s recommendations, Johnson & Johnson, Bayer and other drugmakers could be required to pull their oral medications containing phenylephrine from store shelves. That would likely force consumers to switch to the behind-the-counter pseudoephedrine products or to phenylephrine-based nasal sprays and drops.
According to the article, they’re only discussing the oral medication. Apparently the metabolism process means that almost no phenylephrine gets into the bloodstream when taking orally.
Thanks. I did not see that in the article. The NYT article that someone else posted was more explicit. So I think you are correct. Hate to loose the nose spray version.
Yeah agreed. For oral meds, I always ask for the real pseudoephedrine behind the counter.
Yes, for oral pseudoephedrine works. Not sure why people just do not ask.
The thing about pseudoephedrine, it does not agree with me at prescription strength (not sure I ever had a problem with over the counter version). One time years ago I took prescription strength, if affect my eye muscles, just couldn’t focus. Kind of freaked me out, so I avoid. Just me.
From the article: